Safety & Feasibility of Hypertonic Saline Solution After Aneurysmal

Status Recruiting

Clinical Trial Summary

Subarachnoid hemorrhage (SAH) occurs after rupture of cerebral aneurysms. Treatment of SAH focuses on avoiding medical complications including cerebral vasospasm, which may result in limited circulation to the brain. Cerebral vasospasm, or thinning of the arteries of the brain, is a feared complication that could potentially cause stroke and worst outcomes after SAH. Hypertonic saline (HTS) is a compound that may be used to prevent vasospasm following SAH by enhancing the circulation in the brain. This study will evaluate if a protocol of volume expansion with HTS is safe and effective in patients with subarachnoid hemorrhage for the prevention of cerebral vasospasm.

Clinical Trial Description

This is a prospective, single-center, interventional, randomized, parallel, two-arm (1:1) phase II clinical trial with blinded end-point ascertainment designed to determine the safety and feasibility of a protocol of 3% hypertonic saline (HTS) as a "volume expander" administered within 72-hours of admission and up to 7-days in SAH patients compared to standard fluid management, in individuals with aneurysmal SAH. A common sequela of aneurysmal SAH is vasospasm, which causes significant morbidity and mortality. In addition, 30% of patients with SAH develop hypovolemic hyponatremia (serum sodium [Na] <130mEq/L), predisposing them to develop cerebral ischemia. Current guidelines for the management of aneurysmal SAH recommend: (1) maintaining euvolemia in order to prevent delayed cerebral ischemia (DCI) and (2) using HTS as a treatment option for the prevention and treatment of hypovolemic hyponatremia. Treatment for vasospasm includes induction of hypertension, along with systemic and/or intra-arterial administration of calcium channel blockers, or angioplasty. The investigators will (1) measure the incidence of severe adverse events from our protocol of HTS, (2) measure the incidence of cerebral vasospasm in patients treated with our protocol of HTS as compared to patients treated with standard fluid therapy; and (3) assess the burden of hypovolemic hyponatremia. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02432157
Study type	Interventional
Source	Thomas Jefferson University
Contact	Fred Rincon, MD
Email	fred.rincon@jefferson.edu
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	January 2015

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06043167` - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Recruiting	`NCT04189471` - Recovery After Cerebral Hemorrhage
Completed	`NCT03281590` - Stroke and Cerebrovascular Diseases Registry
Completed	`NCT05131295` - Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.	Phase 3
Recruiting	`NCT02962349` - TRansfusion Strategies in Acute Brain INjured Patients	N/A
Completed	`NCT02872857` - Subarachnoid Hemorrhage Recovery And Galantamine	Phase 1/Phase 2
Completed	`NCT03164434` - Influence of Drainage on EVD ICP-signal
Terminated	`NCT02216513` - Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage	Phase 0
Completed	`NCT02389634` - Identification of Novel Molecular Markers for Vasospasm
Completed	`NCT01077206` - High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage	Phase 2/Phase 3
Not yet recruiting	`NCT00905931` - Lycopene Following Aneurysmal Subarachnoid Haemorrhage	Phase 2
Completed	`NCT01261091` - Early Tracheostomy in Ventilated Stroke Patients	N/A
Completed	`NCT00962546` - Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage	N/A
Completed	`NCT00507104` - Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
Completed	`NCT00071565` - Familial Intracranial Aneurysm Study II	N/A
Recruiting	`NCT05113381` - The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of IVH	N/A
Completed	`NCT04052646` - Prehospital Deaths From Spontaneous Subarachnoid Haemorrhages
Recruiting	`NCT04548596` - NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
Recruiting	`NCT06033378` - Blood Pressure Treatment in ICU Patients With Subarachniodal Haemorrhage.	N/A
Completed	`NCT04308577` - Diet Induced Ketosis for Brain Injury - A Feasibility Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage: — HS3

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms